Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cocoa

Cocoa

Tekturna's Loss May Be Entresto's Gain As Novartis Hopes For Change In The ATMOSPHERE

The negative outcome of Novartis AG's old blood pressure drug Tekturna in the ATMOSPHERE heart failure study highlights the strength of the company's new therapy Entresto.

Metabolic Disorders Cardiovascular Sweden

Amgen's Statin Intolerance Study May Not Cure What Ails PCSK9 Inhibitors

Amgen Inc.'s well-designed GAUSS-3 study shows a role of its PCSK9 inhibitor Repatha in patients who truly can't tolerate statins, but how this translates into real-world utilization in the highly cost-conscious cardiology space remains to be seen.

Neurology Clinical Trials
UsernamePublicRestriction

Register